Valuation: Shivalik Rasayan Limited

Market Cap 6.18B 64.2M 57.08M 53.35M 48.67M 91.31M 92.66M 645M 250M 3.15B 241M 236M 10.15B P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 7.07B 73.38M 65.24M 60.98M 55.63M 104M 106M 737M 285M 3.6B 275M 270M 11.61B EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
42.93%
Yield 2025
0.08%
Yield 2026 0.23%
08-14 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
25-08-12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-05-29 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
25-04-23 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day-2.24%
1 week-8.95%
Current month-2.24%
1 month+19.72%
3 months+65.74%
6 months+77.02%
Current year+10.31%
1 week 372.15
Extreme 372.15
430.05
1 month 310
Extreme 310
437.9
Current year 206
Extreme 206
437.9
1 year 206
Extreme 206
474.2
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 65.14
Extreme 65.14
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 2018-11-16
Director of Finance/CFO - 2001-10-31
Compliance Officer - 2017-07-31
Director TitleAgeSince
Director/Board Member 64 2018-11-16
Chairman 62 2002-02-22
Director/Board Member 67 2003-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/24 Don 21,500 0.1382%
6/26/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-8.95%-10.32%-47.18% 65.96M
+7.90%-84.18%-79.55%-74.89% 51.81B
-0.67%-6.19%+21.46%+18.35% 33.59B
+1.40%-2.66%+14.29%+38.87% 18.8B
-0.57%-5.06%+27.69%+33.59% 17.43B
-0.60%-5.97%-2.18%-12.33% 14.87B
+0.11%-.--%-.--%-.--% 12.96B
+0.12%0.00%+25.22%+193.39% 11.29B
-1.82%-9.26%+13.63%+2.22% 11.21B
-0.22%-.--%-.--%-.--% 8.3B
Average -0.52%-3.33%+1.02%+15.20% 18.03B
Weighted average by Cap. -0.40%-3.44%-12.45%+0.42%

Financials

2025 2026
Net sales 3.1B 32.14M 28.58M 26.71M 24.37M 45.72M 46.39M 323M 125M 1.58B 121M 118M 5.08B 3.62B 37.55M 33.39M 31.2M 28.47M 53.41M 54.2M 377M 146M 1.84B 141M 138M 5.94B
Net income 167M 1.73M 1.54M 1.44M 1.31M 2.47M 2.5M 17.41M 6.74M 85.07M 6.51M 6.37M 274M 124M 1.29M 1.14M 1.07M 976K 1.83M 1.86M 12.93M 5.01M 63.19M 4.83M 4.73M 204M
Net Debt 768M 7.97M 7.09M 6.62M 6.04M 11.34M 11.5M 80.06M 31M 391M 29.92M 29.27M 1.26B 884M 9.18M 8.16M 7.63M 6.96M 13.06M 13.25M 92.23M 35.72M 451M 34.47M 33.72M 1.45B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
26-10-01 ₹392.55 -2.24% 9,351
26-09-30 ₹401.55 -1.93% 1,442
26-09-29 ₹409.45 -0.09% 6,894
26-09-28 ₹409.80 +0.44% 3,623
26-09-25 ₹408.00 -0.32% 3,939
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock